Since the antiestrogen 4-OHT (the active metabolite of TAM) and the antiprogesterone, mifepristone, induces mitochondrial membrane permeabilization and ROS in breast cancer cells [44], AMPK is well positioned to be a central regulator of autophagy in hormonally treated breast cancer cells [45]. This evidence concerns the gene PRKAA1 and breast carcinoma.